Company intelligence / Profile preview
Gordian Biotechnology
South San Francisco, California, United Statesgordian.bio ↗
- Ownership
- Private
- Employees
- ~30
- Development stage
- Preclinical
01
Overview
Gordian Biotechnology has developed a proprietary high-throughput in vivo drug discovery platform to identify effective therapies for complex age-related diseases. Their technology allows parallel testing of hundreds of gene therapies or interventions within individual animals using advanced delivery systems and single-cell sequencing readouts. The company’s most advanced disclosed asset—a gene therapy targeting FGF19 for NASH—is currently at the preclinical stage. No clinical results have been published as the pipeline remains preclinical.[3][4]
- Therapeutic areas
- OtherGastroenterology
- Modalities
- Gene therapy (notably AAV-based gene therapy)[3][4]Potentially other genetic and molecular therapeutics (via pooled in vivo screening)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on Gordian Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gordian Biotechnology.